Relationships between cortisol, dehydroepiandrosterone sulphate and insulin-like growth factor-I system in dementia

Blessed G., Tomlinson B.E., Roth M. The association between quantitative measures of dementia and of senile changes in the cerebral gray matter of elderly subjects. Br. J. Psychiatry 1968, 114: 795.

Magri F., Locatelli M., Balza G., Molla G., Cuzzoni G., Fioravanti M., Solerte S.B., Ferrari E. Changes in endocrine circadian rhythms as markers of physiological and pathological brain aging. Chronobiol. Int. 1997, 14: 385.

O’Brien J.T., Schweitzer I., Ames D., Tuckwell V., Mastwyk M. Cortisol suppression by dexamethasone in the healthy elderly: effect of age, dexamethasone levels, and cognitive function. Biol. Psychiatry 1994, 36: 389.

Mc Ewen B.S. Stress and aging hippocampus. Front. Neuroendocrinol. 1999, 20: 49.

Behl C., Lezoualc’h F., Trapp T., Widman M., Skutella T., Holsboer F. Glucocorticoids enhance oxidative stress-induced cell death in hippocampal neurons in vitro. Endocrinology 1997, 138: 101.

De Kloet E.R., Vreugdenhil E., Oitzl M.S., Joëls M. Brain corticosteroids receptor balance in health and disease. Endocr. Rev. 1998, 19: 269.

Baulieu E.E., Robel P. Dehydroepiandrosterone and dehydroepiandrosterone sulfate as neuroactive neurosteroids. J. Endocrinol. 1996, 150: S221.

Kalimi M., Shafagoj Y., Loria R., Padgett D., Regelson W. Antiglucocorticoid effects of dehydroepiandrosterone (DHEA). Mol. Cell. Biochem. 1994, 131: 99.

Diamond D.M., Branch B.J., Fleschner M., Rose G.M. Effects of dehydroepiandrosterone sulfate and stress on hippocampal electrophysiological plasticity. Ann. N.Y. Acad. Sci. 1995, 774: 304.

Kimonides V.G., Khatibi N.H., Svendsen C.N., Sofroniew M.V., Herbert J. Dehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEAS) protect hippocampal neurons against excitatory amino acid-induced neurotoxicity. Proc. Natl. Acad. Sci. USA 1998, 95: 1852.

Guazzo E.P., Kirkpatrick P.J., Goodyer I.M., Shiers H.M., Herbert J. Cortisol, dehydroepiandrosterone (DHEA), and DHEA sulfate in the cerebrospinal fluid of man: relation to blood levels and the effects of age. J. Clin. Endocrinol. Metab. 1996, 81: 3951.

Berr C., Lafont S., Debuire B., Dartigues J.F., Baulieu E.E. Relationship of dehydroepiandrosterone sulfate in the elderly with functional, psychological, and mental status, and short term mortality: a French community- based study. Proc. Natl. Acad. Sci. USA 1996, 93: 13410.

Herbert J. Neurosteroids, brain damage, and mental illness. Ex. Gerontol. 1998, 33: 713.

Sunderland T., Merril C.R., Harrington M.G., Lawlor B.A., Molchan S.E., Martinez R., Murphy D.R. Reduced plasma dehydroepiandrosterone concentrations in Alzheimer’s disease. Lancet 1989, ii: 570.

Näsman B., Olsson T., Backstrom T., Eriksson S., Grankvist K., Viitanen M., Bucht G. Serum dehydroepiandrosterone sulfate in Alzheimer’s disease and multi-infarct dementia. Biol. Psychiatry 1991, 30: 684.

Kalmijn S., Launer L.J., Stolk R.P., de Jong F.H., Polk H.A.P., Hofman A., Breteler M.M.B., Lamberts S.W.J. A prospective study on cortisol, dehydroepiandrosterone sulphate, and cognitive function in the elderly. J. Clin. Endocrinol. Metab. 1998, 83: 3487.

Hoffman A.R., Lieberman S.A., Butterfield G., Thompson J., Hintz R.L., Ceda G.P., Marcus R. Functional consequences of somatopause and its treatment. Endocr. Rev. 1997, 7: 73.

Garcia Estrada J., Garcia-Segura L.M., Torres- Aleman I. Expression of Insulin-like growth factor I by astrocytes in response to injury. Brain Res. 1992, 592: 343.

Torres-Aleman I. Insulin-like growth factors as mediators of functional plasticity in the adult brain. Horm. Metab. Res. 1999, 31: 114.

Li J., Owens A., Owens P.C., Saunders J.C., Fowden A.L., Gilmour R.S. The ontogeny of hepatic growth hormone receptors and insulin-like growth factor-I gene expression in the sheep fetus during late gestation: developmental regulation by cortisol. Endocrinology 1996, 137: 1650.

Lee P.D.K., Giudice L.C., Conover C.A., Powell D.R. Insulin-like growth factor binding protein-1: recent findings and new directions. Proc. Soc. Exper. Biol. Med. 1997, 216: 319.

Pfeilschifter J., Scheidt-Nave C., Leidig-Bruckner G., Woitge H.W., Blum W.F., Wüster C., Haack D., Ziegler R. Relationship between circulating insulin-like growth factor components and sex hormones in a population- based sample of 50- to 80-year-old men and women. J. Clin. Endocrinol. Metab. 1996, 81:2534.

Morales A.J., Nolan J.J., Nelson J.C., Yen S.S.C. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J. Clin. Endocrinol. Metab. 1994, 78: 1360.

Casson P.R., Santoro N., Elkind-Hirsch K., Carson S.A., Hornsby P.J., Abraham G., Buster J.E. Postmenopausal dehydroepiandrosterone administration increases free insulin-like growth factor-I and decreases high-density lipoprotein: a six-month trial. Fertil. Steril. 1998, 70: 107.

Jones J., Clemmons D.R. Insulin-like growth factors and their binding proteins: biological actions. Endocr. Rev. 1995, 16: 3.

McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS/ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 1984, 34: 939.

Folstein M.F., Folstein S.E., McHughes P.R. Mini Mental State: a practical method for grading the cognitive state of patients for clinicians. J. Psychiatry Res. 1975, 12: 189.

Reisberg B., Ferris S., De Leon M.J., Croock T. The global deterioration scale for assessment of primary degenerative dementia. Am. J. Psychiatry 1982, 139: 1136.

Daughaday W.H., Mariz I.K., Blethen S.L. Inhibition of access of bound somatomedin to membrane receptor and immunoglobin sites: a comparison of radioreceptor and radioimmunoassay of somatomedin in native and acid-ethanol extracted serum. J. Clin. Endocrinol. Metab. 1980, 51: 781.

Juul A., Dalgaard P., Blum W.F., Bang P., Hall K., Michaelsen K.F., Müller J., Skakkerbæk N.E. Serum levels of insulin like growth factors (IGF) binding protein 3 (IGFBP-3) in healthy infants, children and adolescents: the relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index and pubertal maturation. J. Clin. Endocrinol. Metab. 1995, 80: 2534.

Armitage P., Berry G. Statistical methods in medical research, 2nd ed. Blackwell Scientific Publications, Oxford, 1987, p. 327.

Hartmann A., Veldhuis J.D., Deuschle M., Standhardt H., Heuser I. Twenty-four hour cortisol release profiles in patients with Alzheimer’s and Parkinson’s disease compared to normal controls: ultradian secretory pulsatility and diurnal variation. Neurobiol. Aging 1997, 18: 285.

Hatzinger M., Z’Brun A., Hemmeter U., Seifritz E., Baumann F., Holsboer-Trachsler E., Heuser I. Hypothalamic-pituitary-adrenal system function in patients with Alzheimer’s disease. Neurobiol. Aging 1995, 16: 205.

Weiner M.F., Vobach S., Olsson K., Svetlik D., Risser R.C. Cortisol secretion and Alzheimer’s disease. Biol. Psych. 1997, 42: 1030.

Herman J., Schafer M.K.-H., Young E., Thompson R., Douglass J., Akil H., Watson S.J. Evidence for hippocampal regulation of neuroendocrine neurons of hypothalamo-pituitary-adrenocortical axis. J. Neurosci. 1989, 9: 3072.

Jacobson L., Sapolsky R. The role of the hippocampus in feedback regulation of the hypothalamic-pituitary-adrenocortical axis. Endocr. Rev. 1991, 12: 118.

Sapolski R., Krey L., McEwen B.S. The neuroendocrinology of stress and aging: The glucocorticoid cascade hypothesis. Endocr. Rev. 1986, 7: 284.

De Leon M.J., Mc Rae T., Tsai J.R., George A.E., Marcus D.L., Freedman M., Wolf A.P., McEwen B.S. Abnormal cortisol response in Alzheimer’s disease linked to hippocampal atrophy. Lancet 1988, ii: 391.

Svec F., Lopez A. Antiglucocorticoid actions of dehydroepiandrosterone and low concentration in Alzheimer’s disease. Lancet 1989, i: 1335.

Schneider L.S., Hinsey M., Lyness S. Plasma dehydroepiandrosterone sulfate in Alzheimer’s disease. Biol. Psychiatry 1992, 31: 205.

Sara V.R., Hall K., Ensell K., Gardner A., Morawski R., Wetterberg L. Somatomedins in aging and in dementia of the Alzheimer type. Neurobiol. Aging 1982, 3: 117.

Tham A., Sparring K., Bowen D., Wetterberg L., Sara V.R. Insulin-like growth factors and somatomedin B in the cerebrospinal fluid of patients with dementia of the Alzheimer type. Acta Psychiatr. Scand. 1988, 77: 719.

Tham A., Nordberg A., Grissom F.E., Carlsson- Skwirut C., Viitanen M., Sara V.R. Insulin-like growth factors and insulin-like growth factor binding proteins in cerebrospinal fluid and serum of patients with dementia of the Alzheimer type. J. Neural Transm. 1993, 5: 165.

Conover C.A., Clarkson J.T., Bale L.K. Effect of glucocorticoids on insulin-like growth factor regulation of IGF-binding protein expression in fibroblasts. Endocrinology 1995, 136: 1403.

Conover C.A., Divertie G.D., Lee P.D.K. Cortisol increases plasma insulin-like growth factor binding protein-1 in humans. Acta Endocrinol. (Copenh.) 1993, 128: 140.

Katz L.E.L., Satin-Smith M.S., Collet-Solberg P., Baker L., Stanley C.A., Cohen P. Dual regulation of insulin-like growth factor binding protein 1 levels by insulin and cortisol during fasting. J. Clin. Endocrinol. Metab. 1998, 83: 4426.

Rollero A., Murialdo G., Fonzi S., Garrone S., Gianelli M.V., Gazzerro E., Barreca A., Polleri A. Relationship between cognitive function, growth hormone and Insulin-like growth factor-I plasma levels in aged subjects. Neuropsychobiology 1998, 38: 73.

Lupien SJ., Gaudreau S., Tchiteya B.M., Maheu F., Sharma S., Nair N.P.V., Hauger R.L., McEwen B.S., Meaney M.J. Stress-induced declarative memory impairment in healthy elderly subjects: relationship to cortisol reactivity. J. Clin. Endocrinol. Metab. 1997, 82: 2070.

Rhodes M.E., Li P.K., Burke A.M., Johnson D.A. Enhanced plasma DHEAS, brain acetylcholine and memory mediated by steroid sulfatase inhibition. Brain Res. 1997, 773: 28.